Hepatitis C virus NS5A targets the nucleosome assembly protein NAP1L1 to control the interferon response
Hepatitis C virus (HCV) is a hepatotropic virus affecting more than 150 million people worldwide. HCV establishes a chronic infection in the majority of cases, which leads to severe liver complications such as cirrhosis and hepatocellular carcinoma. Fortunately, recent potent direct acting antiviral...
Main Author: | |
---|---|
Published: |
Open University
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.713931 |